Literature DB >> 9673244

An epitope delivery system for use with recombinant mycobacteria.

C Hetzel1, R Janssen, S J Ely, N M Kristensen, K Bunting, J B Cooper, J R Lamb, D B Young, J E Thole.   

Abstract

We have developed a novel epitope delivery system based on the insertion of peptides within a permissive loop of a bacterial superoxide dismutase molecule. This system allowed high-level expression of heterologous peptides in two mycobacterial vaccine strains, Mycobacterium bovis bacille Calmette-Guérin (BCG) and Mycobacterium vaccae. The broader application of the system was analyzed by preparation of constructs containing peptide epitopes from a range of infectious agents and allergens. We report detailed characterization of the immunogenicity of one such construct, in which an epitope from the Der p1 house dust mite allergen was expressed in M. vaccae. The construct was able to stimulate T-cell hybridomas specific for Der p1, and it induced peptide-specific gamma interferon responses when used to immunize naive mice. This novel expression system demonstrates new possibilities for the use of mycobacteria as vaccine delivery vehicles.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9673244      PMCID: PMC108397          DOI: 10.1128/IAI.66.8.3643-3648.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Molecular characterization of a surface-exposed superoxide dismutase of Mycobacterium avium.

Authors:  V Escuyer; N Haddad; C Frehel; P Berche
Journal:  Microb Pathog       Date:  1996-01       Impact factor: 3.738

2.  T cell epitope analysis with peptides simultaneously synthesized on cellulose membranes: fine mapping of two DQ dependent epitopes.

Authors:  S Adler; R Frank; A Lanzavecchia; S Weiss
Journal:  FEBS Lett       Date:  1994-09-26       Impact factor: 4.124

Review 3.  Development of an emulsion-based muramyl dipeptide adjuvant formulation for vaccines.

Authors:  D M Lidgate; N E Byars
Journal:  Pharm Biotechnol       Date:  1995

4.  Sequence polymorphisms of cDNA clones encoding the mite allergen Der p I.

Authors:  K Y Chua; P K Kehal; W R Thomas
Journal:  Int Arch Allergy Immunol       Date:  1993       Impact factor: 2.749

5.  The promise of immunotherapy for tuberculosis.

Authors:  J L Stanford; J M Grange
Journal:  Respir Med       Date:  1994-01       Impact factor: 3.415

6.  X-ray structure analysis of the iron-dependent superoxide dismutase from Mycobacterium tuberculosis at 2.0 Angstroms resolution reveals novel dimer-dimer interactions.

Authors:  J B Cooper; K McIntyre; M O Badasso; S P Wood; Y Zhang; T R Garbe; D Young
Journal:  J Mol Biol       Date:  1995-03-03       Impact factor: 5.469

7.  Transformation of mycobacterial species using hygromycin resistance as selectable marker.

Authors:  T R Garbe; J Barathi; S Barnini; Y Zhang; C Abou-Zeid; D Tang; R Mukherjee; D B Young
Journal:  Microbiology       Date:  1994-01       Impact factor: 2.777

Review 8.  Adjuvants for human vaccines--current status, problems and future prospects.

Authors:  R K Gupta; G R Siber
Journal:  Vaccine       Date:  1995-10       Impact factor: 3.641

9.  A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity.

Authors:  B Scott; R Liblau; S Degermann; L A Marconi; L Ogata; A J Caton; H O McDevitt; D Lo
Journal:  Immunity       Date:  1994-04       Impact factor: 31.745

10.  Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.

Authors:  C K Stover; G P Bansal; M S Hanson; J E Burlein; S R Palaszynski; J F Young; S Koenig; D B Young; A Sadziene; A G Barbour
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  4 in total

1.  Analysis of recombinant mycobacteria as T helper type 1 vaccines in an allergy challenge model.

Authors:  R Janssen; A Kruisselbrink; L Hoogteijling; J R Lamb; D B Young; J E Thole
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

2.  Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env.

Authors:  Mark J Cayabyab; Avi-Hai Hovav; Tsungda Hsu; Georgia R Krivulka; Michelle A Lifton; Darci A Gorgone; Glenn J Fennelly; Barton F Haynes; William R Jacobs; Norman L Letvin
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Identification of promiscuous epitopes from the Mycobacterial 65-kilodalton heat shock protein recognized by human CD4(+) T cells of the Mycobacterium leprae memory repertoire.

Authors:  A S Mustafa; K E Lundin; R H Meloen; T M Shinnick; F Oftung
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

4.  A recombinant BCG vaccine generates a Th1-like response and inhibits IgE synthesis in BALB/c mice.

Authors:  M Kumar; A K Behera; H Matsuse; R F Lockey; S S Mohapatra
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.